Nahdi closes at record low
Shares of Nahdi Medical Co. dropped 2% to close at SAR 137.20, the lowest since debut on the main market (TASI), with nearly 436,000 shares traded.
| Year High (SAR) | Year Low (SAR) |
| 209.20 | 137.20 |
| Highest Since Debut (SAR) | Lowest Since Debut (SAR) |
| 209.40 | 137.20 |
Thus, the stock's year-to-date (YTD) losses reached 16% and 12-month losses hit almost 30%.
Market Data :
| Open | 91.45 |
| Low | 90.50 |
| High | 91.50 |
| Previous Close | 91.50 |
| Change (3M) | (2.10 %) |
| Change (6M) | (14.25 %) |
| Market Value | 11,817.00 |
| Avg. Volume (3M) | 116,494.12 |
| Avg. Turnover (3M) | 10,823,080.08 |
| Avg. Transaction (3M) | 1,308.48 |
| Change(12M) | (24.19 %) |
| YTD | (4.32 %) |
The company did not carry out any changes to its capital since debut in 2022.
Adjustments to the capital (M Riyal) :
| Date | Type | Capital (M Riyal) | Change (%) |
| 2022 | IPO | 1,300.00 | 0.00% |
Financial Performance :
Overview :
The company was established in 1986 as a sole proprietorship operating two pharmacies in Jeddah under the name Abdullah Amer bin Munif Al-Nahdi Establishment. In 2003, it converted into a limited liability company and changed its name to Abdullah Amer bin Munif AlNahdi & Partners Company for Pharmacies and Medical Equipment with capital of SAR 50 million, before rebranding to Nahdi Medical Co. one year later. The company underwent several legal transformations, converting into a closed joint...
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Financial Ratios :
| Financial Ratio | Current |
| Market Cap (M Riyal) | 11,817.01 |
| Shares Outstanding ((M)) | 130.00 |
| Recurring EPS ( Riyal) (TTM) | 6.06 |
| Book Value (BV) ( Riyal) (Latest announcement) | 19.32 |
| Recurring P/E (TTM) | 14.99 |
| Price/book | 4.70 |
| Dividend Yield (%) (Last Year) | 6.16 |
| Return on Average Assets (%) (TTM) | 11.94 |
| Return on Average Equity (%) (TTM) | 30.31 |
| Par Value ( Riyal) | 10.00 |
| Enterprise Value (EV) (M Riyal) | 11,306.36 |
| EV/adj EBITDA | 6.64 |
| EV/ EBITDA | 6.60 |
| EV/Revenues | 1.07 |
Calendar :
-
23 October
General Assembly
- -
21 March
Ex-dividend Date
- -
02 April
Cash Dividend Distribution
- -
28 May
General Assembly
- -
11 August
Ex-dividend Date
- -
25 August
Cash Dividend Distribution
-
Analyst Estimates :
197
Fair Average Price
2
Number of Recommendations
| Rating | Research firm | Current Price | Target Price | Change | |
| Neutral | Citi Bank Group | 157.00 | 180.00 | 14.65 % | |
| Buy | Riyad Capital | 175.40 | 214.00 | 22.01 % |
Call Request
Comments Analysis: